Perry Gordon

869 total citations
9 papers, 280 citations indexed

About

Perry Gordon is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Perry Gordon has authored 9 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Perry Gordon's work include Protease and Inhibitor Mechanisms (4 papers), Bone Metabolism and Diseases (3 papers) and Natural product bioactivities and synthesis (2 papers). Perry Gordon is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Bone Metabolism and Diseases (3 papers) and Natural product bioactivities and synthesis (2 papers). Perry Gordon collaborates with scholars based in United States, United Kingdom and South Korea. Perry Gordon's co-authors include S. Cyrus Khojasteh, Kyoung‐Jin Lee, Kevin R. Holme, Patrick J. Sinko, Yong‐Hee Lee, Jonathan Chang, Tove Tuntland, Arnab K. Chatterjee, Donald S. Karanewsky and Michael J. Roberts and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Pharmaceutical Research and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Perry Gordon

9 papers receiving 271 citations

Peers

Countries citing papers authored by Perry Gordon

Since Specialization

Citations

This map shows the geographic impact of Perry Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Gordon more than expected).

Fields of papers citing papers by Perry Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Gordon. The network helps show where Perry Gordon may publish in the future.

Co-authorship network of co-authors of Perry Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Gordon. A scholar is included among the top collaborators of Perry Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Gordon. Perry Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer 2019 ·Proceedings of the National Academy of Sciences ·Natasha C. Lucki, Genaro R. Villa, (unknown), Michael J. Bollong, (unknown), Jae Wook Lee, Justin L. Anglin, (unknown), Emily N. Chin, (unknown), Kevin C. Johnson, Philipp N. Sander, Perry Gordon, Stephen Skirboll, Heiko Wurdak, Peter G. Schultz, Paul S. Mischel, Luke L. Lairson	25
2	A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil 2014 ·Drug Metabolism Reviews ·Perry Gordon, S. Cyrus Khojasteh	25
3	Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Phil B. Alper, Thomas H. Marsilje, Daniel Mutnick, Wenshuo Lu, Arnab K. Chatterjee, Michael J. Roberts, Yun He, Donald S. Karanewsky, Donald Chow, Jianmin Lao, (unknown), Tove Tuntland, Bo Liu, Jonathan Chang, Perry Gordon, H. Martin Seidel, Shin‐Shay Tian	24
4	Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S 2007 ·Bioorganic & Medicinal Chemistry Letters ·Arnab K. Chatterjee, Hong Liu, David C. Tully, Jianhua Guo, Robert Epple, (unknown), Jennifer Williams, Michael J. Roberts, Tove Tuntland, Jonathan Chang, Perry Gordon, Thomas Hollenbeck, Christine Tumanut, Jun Li, Jennifer L. Harris	11
5	Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hong Liu, Arnab K. Chatterjee, (unknown), David C. Tully, Christine Tumanut, Jun Li, Jennifer L. Harris, Tove Tuntland, Jonathan Chang, Perry Gordon, Thomas Hollenbeck, Donald S. Karanewsky	14
6	Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·David C. Tully, Hong Liu, Arnab K. Chatterjee, Phil B. Alper, Jennifer Williams, Michael J. Roberts, Daniel Mutnick, David H. Woodmansee, Thomas Hollenbeck, Perry Gordon, Jonathan Chang, Tove Tuntland, Christine Tumanut, Jun Li, Jennifer L. Harris, Donald S. Karanewsky	21
7	Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers 2006 ·Bioorganic & Medicinal Chemistry Letters ·David C. Tully, Hong Liu, Arnab K. Chatterjee, Phil B. Alper, Robert Epple, Jennifer Williams, Michael J. Roberts, David H. Woodmansee, (unknown), Christine Tumanut, Jun Li, Glen Spraggon, Michael Hornsby, Jonathan Chang, Tove Tuntland, Thomas Hollenbeck, Perry Gordon, Jennifer L. Harris, Donald S. Karanewsky	26
8	Identification of novel potent bicyclic peptide deformylase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Valentina Molteni, (unknown), (unknown), (unknown), Andreas Kreusch, Perry Gordon, Badry Bursulaya, (unknown), (unknown), Tanya Biorac, Neil S. Ryder, (unknown), John Doughty, Yun He	32
9	Modulation of Nonspecific Binding in Ultrafiltration Protein Binding Studies 2003 ·Pharmaceutical Research ·Kyoung‐Jin Lee, (unknown), (unknown), (unknown), (unknown), Perry Gordon, Patrick J. Sinko, Kevin R. Holme, Yong‐Hee Lee	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact